Continuum Advisory’s Incyte INCY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$35.7K Buy
+315
New +$31.2K ﹤0.01% 881
2026
Q1
Sell
-74,181
Closed -$7.33M 466
2025
Q4
$7.33M Buy
74,181
+356
+0.5% +$34.4K 0.73% 25
2025
Q3
$6.26M Buy
73,825
+5,185
+8% +$410K 0.66% 33
2025
Q2
$4.67M Buy
68,640
+6,552
+11% +$415K 0.56% 40
2025
Q1
$3.76M Buy
62,088
+61,535
+11,127% +$4.29M 0.48% 45
2024
Q4
$38.2K Sell
553
-27
-5% -$1.92K ﹤0.01% 715
2024
Q3
$45.1K Sell
580
-53,510
-99% -$3.41M 0.01% 673
2024
Q2
$3.28M Buy
54,090
+1,662
+3% +$94.1K 0.47% 42
2024
Q1
$2.8M Buy
52,428
+22,988
+78% +$1.38M 0.42% 52
2023
Q4
$1.85M Buy
29,440
+7,512
+34% +$425K 0.26% 102
2023
Q3
$1.27M Buy
+21,928
New +$1.38M 0.2% 138

Other funds holding INCY

Continuum Advisory's INCY Position: Q2 2026 in Review

Continuum Advisory opened a new position in Incyte (INCY) in Q2 2026: 315 shares worth $35.7K. The stake represents ﹤0.01% of the portfolio and ranks #881 among its holdings. This is a return to the name: Continuum Advisory previously reported a position in INCY as recently as Q4 2025.

Continuum Advisory first reported a position in INCY in Q3 2023 and has held it in 11 quarters since. The position peaked at $7.33M in Q4 2025. 859 funds tracked by Wall St. Rank hold INCY as of Q2 2026.

  • Continuum Advisory held 315 shares of Incyte worth $35.7K as of Q2 2026.
  • Incyte was a new Continuum Advisory position in Q2 2026.
  • Incyte made up ﹤0.01% of Continuum Advisory's portfolio in Q2 2026, its #881 holding.
  • Continuum Advisory first reported a position in Incyte in Q3 2023 and has held it in 11 quarters since.
  • Continuum Advisory's Incyte position peaked at $7.33M in Q4 2025.
  • 859 funds tracked by Wall St. Rank held Incyte as of Q2 2026.

Based on Continuum Advisory's 13F filing for Q2 2026, filed 6 Aug 2026.